• Free & confidential
  • No obligation
  • No fees unless you win
  • 48 documented verdicts on file

From the docket

Major investigations

All 51 →
Product LiabilityBard PowerPort CatheterThe Bard PowerPort is an implantable venous access device — a small port placed under the skin, typically in the chest — that allows medical professionals to administer chemotherapy, draw blood, and deliver medications without repeated needle sticks. Millions of patients have received PowerPort devices since C.R. Bard introduced them in the 1990s. The devices are especially common among cancer patients who require long-term intravenous access. Beginning in the early 2010s, patients, physicians, and researchers began documenting a disturbing pattern: the polyurethane catheter tubing attached to the port was fracturing inside the body. Fragments of the catheter — sometimes several centimeters long — were entering the bloodstream and migrating toward the heart and lungs. The resulting complications range from serious to fatal: cardiac perforation, cardiac tamponade, pulmonary embolism, sepsis, and endocarditis. Becton Dickinson (BD) acquired C.R. Bard in 2017 for $24 billion, inheriting both the PowerPort product line and the mounting litigation. In 2022, a federal multidistrict litigation was established in the U.S. District Court for the District of Arizona to consolidate cases nationwide. Legal claims proceed under theories of design defect, manufacturing defect, failure to warn, and negligence.Read the investigation
Product LiabilityZantac / Ranitidine (NDMA Cancer)Ranitidine, sold under the brand name Zantac by Sanofi and previously by GSK, Pfizer, and Boehringer Ingelheim, was one of the most prescribed heartburn and acid reflux medications in history. In 2019, the independent pharmaceutical testing laboratory Valisure discovered that ranitidine is inherently unstable and produces NDMA — N-nitrosodimethylamine, a probable human carcinogen — at levels up to 304,500 nanograms per tablet. The FDA acceptable daily intake limit for NDMA is 96 nanograms. In April 2020, the FDA requested that all manufacturers withdraw ranitidine products from the U.S. market. Consumers who took Zantac regularly for a year or more and subsequently developed bladder, stomach, colorectal, breast, prostate, or esophageal cancer may have viable legal claims. A federal MDL in the Southern District of Florida was dismissed in November 2022 when Judge Robin Rosenberg excluded plaintiffs' general causation experts under Daubert, finding their methodologies unreliable. However, that ruling applies only to federal court and does not bind state courts. Litigation continues in Delaware Superior Court and California state courts in 2026, where different expert standards and case-specific evidence can support claims.Read the investigation
Institutional AbuseNursing Home Abuse & Elder AbuseNursing home abuse is a pervasive crisis affecting the most vulnerable members of our society. Approximately 1.5 million Americans reside in nursing homes and long-term care facilities, and a significant proportion experience some form of abuse, neglect, or exploitation. The federal government regulates nursing home quality through the Centers for Medicare and Medicaid Services (CMS), which publishes a five-star rating system and conducts regular health inspections — yet facilities with poor ratings continue to operate, understaffed and underfunded, leaving residents at serious risk. Types of abuse range from physical assault and sexual abuse to financial exploitation, emotional cruelty, and systematic neglect of basic care needs. When nursing homes and assisted living facilities breach their legal duty of care, they can be held liable for the full range of damages suffered by residents and their families, including medical expenses, pain and suffering, emotional distress, and in egregious cases, punitive damages designed to deter future misconduct.Read the investigation
EnvironmentalAFFF Firefighting FoamAFFF firefighting foam containing per- and polyfluoroalkyl substances (PFAS) has been used since the 1960s at military bases, airports, and fire training facilities across the United States. These "forever chemicals" do not break down in the environment and have contaminated groundwater, soil, and drinking water supplies serving millions of Americans. The C8 Science Panel established "probable links" between PFAS exposure and six diseases including kidney cancer, testicular cancer, and thyroid disease. MDL 2873, consolidated before Judge Richard Gergel in the District of South Carolina, encompasses over 15,216 personal injury claims against manufacturers including 3M, DuPont, Chemours, Tyco Fire Products, and BASF. Water utility settlements exceeding $12.5 billion have been approved, and the personal injury track is advancing toward bellwether trials with Daubert motions and expert depositions underway.Read the investigation
EnvironmentalAsbestos / MesotheliomaMesothelioma is a rare and deadly cancer of the lining of the lungs (pleura), abdomen (peritoneum), or heart (pericardium), caused in virtually every case by exposure to asbestos. Asbestos was widely used in construction, shipbuilding, insulation, automotive repair, and industrial applications throughout most of the 20th century. Workers in these industries — as well as their family members who were exposed through contaminated clothing — face a dramatically elevated risk of mesothelioma, asbestos-related lung cancer, and asbestosis decades after their last exposure. The legal landscape for mesothelioma victims is unique: more than 60 major asbestos manufacturers have filed for bankruptcy and established trust funds totaling over $30 billion. Veterans — particularly Navy veterans who worked in engine rooms and shipyards — account for approximately 30% of all mesothelioma diagnoses. Because mesothelioma has a grim prognosis and the legal process moves faster than in typical personal injury cases, acting quickly after diagnosis is essential to ensuring you and your family receive full compensation.Read the investigation
Product LiabilityInstant Soup BurnsInstant soup products designed in cup or bowl form are a staple of American households, yet their design creates a foreseeable and recurring hazard: scalding liquid spills onto consumers when the lightweight cup tips or collapses. Children under five are disproportionately affected because they are more likely to encounter unattended cups of hot soup at table or counter height and because their skin is thinner and more vulnerable to deep burns at lower temperatures and shorter contact durations. Product liability law allows burn victims to sue manufacturers under three distinct theories — design defect, manufacturing defect, and failure to warn — without needing to prove the company acted with any particular intent. The CPSC has received hundreds of burn injury reports related to instant cup soups. An experienced product liability attorney can hold manufacturers accountable and recover compensation for medical treatment, scarring, pain and suffering, and in child cases, the long-term emotional and cosmetic impact of permanent disfigurement.Read the investigation

The process

Free to you, start to finish

  1. 01

    Tell us what happened

    Answer a few plain-language questions. It takes about two minutes, and nothing is shared until you say so.

  2. 02

    We check it against the record

    Your answers are matched against the eligibility criteria attorneys are actually using in each litigation.

  3. 03

    Talk to a vetted attorney — or don’t

    If you qualify, we connect you with an experienced firm. Free either way, and no fees unless you win.

From the verdict database

What juries have said this is worth

All 48 verdicts →
$2.12B
Talcum Powder
A St. Louis jury awarded $4.69 billion to 22 women diagnosed with ovarian cancer after using J&J talcum powder products, including $4.14 billion in punitive damages and $550 million in compensatory damages. The Missouri Court of Appeals later reduced the award to $2.12 billion by striking the claims of plaintiffs without sufficient connection to Missouri. Even after reduction, the Ingham verdict remains one of the largest product liability awards in American history and established the template for multi-plaintiff talc trials.
INGHAM V. JOHNSON & JOHNSON (ST. LOUIS, MO) · JURY VERDICT · JUL 2018
See this investigation →
$2.1B
Roundup
A Georgia jury awarded $2.1 billion to a plaintiff diagnosed with non-Hodgkin lymphoma after extensive Roundup exposure — the largest individual Roundup verdict to date. The verdict came after the Supreme Court declined to hear Bayer’s preemption defense, signaling continued legal exposure for the company. Bayer settled the case in November 2025 while it was on appeal.
GEORGIA ROUNDUP VERDICT (MARCH 2025) · JURY VERDICT · MAR 2025
See this investigation →
$1.56B
Talcum Powder
A Baltimore jury returned the largest single-plaintiff talcum powder verdict in history, awarding $1.56 billion to plaintiff in Craft v. Johnson & Johnson. The award comprised $1 billion in punitive damages against J&J, $500 million in punitive damages against Pecos River Talc (a J&J-affiliated entity), and $59.84 million in compensatory damages. The verdict reflected the jury’s response to evidence of J&J’s decades-long concealment of asbestos contamination and cancer risk in its Baby Powder products.
CRAFT V. JOHNSON & JOHNSON (BALTIMORE) · JURY VERDICT · DEC 2025
See this investigation →

Documented verdicts and settlements from public court records, collected by our research team. These are outcomes in other people's cases — never a prediction or promise about yours.

Two minutes to find out where you stand.

Statutes of limitations run quietly. The eligibility check is free, confidential, and doesn't commit you to anything.

People's Justice is not a law firm and does not provide legal advice. This website is an attorney advertising service. The information provided is for general purposes only and does not constitute legal advice. No attorney-client relationship is formed by use of this site. Past results do not guarantee future outcomes. Each case is unique.

Check your eligibility — free